Fusion Gene Analysis Panel

Description

51 genes including ALK, ROS1, RET,
NTRK1/2/3, FGFR1/2/3

Tissue, NA, Fasting or Non Fasting: As suggested by doctor

Sample Required:

FFPE tissue block OR fresh tissue in DCGL Preservative Solution at 2–8°C; tumour content >10%.

Test Time:

Biopsy-dependent. 8–12 working days.

Test Normal Range:

No fixed normal range.

What is the Test?

A fusion-focused NGS panel evaluating **51 genes**, including ALK, ROS1, RET, NTRK1/2/3 and FGFR1/2/3, to identify actionable gene fusions.

Test Procedure:

Tumour RNA/DNA is sequenced to detect fusion events across the 51-gene panel.

When to Take the Test:

When fusion detection is essential for choosing targeted therapy.

Who Should Take This Test:

Patients with lung, thyroid, sarcoma, or other cancers where actionable fusions are common.

Precautions for Exceptional Cases (Pregnancy, etc.):

Ensure adequate fixation; disclose pregnancy and major health conditions.